Gilteritinib

About

Therapy type: Targeted therapy

Therapy strategy: FLT3 inhibition

Mappings

NCI Thesaurus: Gilteritinib (ncit:C116722)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) FLT3-ITD Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835Y Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835A Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835E Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835H Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835N Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835S Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835V Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835A Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835E Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835H Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835N Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835S Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835V Acute Lymphoid Leukemia Gilteritinib
Sensitivity (+) FLT3-ITD Acute Myeloid Leukemia Gilteritinib
Sensitivity (+) FLT3 p.D835Y Acute Myeloid Leukemia Gilteritinib